The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Ras homolog gene family H (RhoH) deficiency induces psoriasis-like chronic dermatitis by promoting TH17 cell polarization
Abstract
Background Ras homolog gene family H (RhoH) is a membrane-bound adaptor protein involved in proximal T-cell receptor signaling. Therefore RhoH plays critical roles in the differentiation of T cells; however, the function of RhoH in the effecter phase of the T-cell response has not been fully characterized. Objective We sought to explore the role of RhoH in inflammatory immune responses and investigated the involvement of RhoH in the pathogenesis of psoriasis. Methods We analyzed effector T-cell and systemic inflammation in wild-type and RhoH-null mice. RhoH expression in T cells in human PBMCs was quantified by using RT-PCR. Results RhoH deficiency in mice induced T H 17 polarization during effector T-cell differentiation, thereby inducing psoriasis-like chronic dermatitis. Ubiquitin protein ligase E3 component N-recognin 5 (Ubr5) and nuclear receptor subfamily 2 group F member 6 (Nr2f6) expression levels decreased in RhoH-deficient T cells, resulting in increased protein levels and DNA binding activity of retinoic acid-related orphan receptor γt. The consequential increase in IL-17 and IL-22 production induced T cells to differentiate into T H 17 cells. Furthermore, IL-22 binding protein/Fc chimeric protein reduced psoriatic inflammation in RhoH-deficient mice. Expression of RhoH in T cells was lower in patients with psoriasis with very severe symptoms. Conclusion Our results indicate that RhoH inhibits T H 17 differentiation and thereby plays a role in the pathogenesis of p…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“RHOH exhibits high expression in T cells and plays crucial roles in T cell development, activation and differentiation [18–21]”
From Nascent RHOH acts as a molecular brake on actomyosin-mediated effector functions of inflammatory neutrophils (2022) · cites this paper as [21]
Citations
Cites
Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections
Crequer, A., Troeger, A., Patin, E., Ma, C. S., Picard, C., Pedergnana, V., Fieschi, C., Lim, A., Abhyankar, A., Gineau, L., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62949 · Cited by 159
Gu, Y., Chae, H.-D., Siefring, J. E., Jasti, A. C., Hildeman, D. A., & Williams, D. A. (2006) · Nature Immunology · doi:10.1038/ni1396 · Cited by 110
Hematopoietic-specific Rho GTPases Rac2 and RhoH and human blood disorders
Troeger, A., & Williams, D. A. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.07.002 · Cited by 73
Troeger, A., Johnson, A. J., Wood, J., Blum, W. G., Andritsos, L. A., Byrd, J. C., & Williams, D. A. (2012) · Blood · doi:10.1182/blood-2011-12-395939 · Cited by 55
RhoH Regulates Subcellular Localization of ZAP-70 and Lck in T Cell Receptor Signaling
Chae, H.-D., Siefring, J. E., Hildeman, D. A., Gu, Y., & Williams, D. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013970 · Cited by 35
RhoH Plays Critical Roles in FcεRI-Dependent Signal Transduction in Mast Cells
Oda, H., Fujimoto, M., Patrick, M. S., Chida, D., Sato, Y., Azuma, Y., Aoki, H., Abe, T., Suzuki, H., & Shirai, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.2.957 · Cited by 29
Self-citationOverexpression of RhoH Permits to Bypass the Pre-TCR Checkpoint
Tamehiro, N., Oda, H., Shirai, M., & Suzuki, H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0131047 · Cited by 14
Self-citation
Research works printed but not linked: 50
- Wang, 2011, RhoH modulates pre-TCR and TCR signalling by regulating LCK, Cell Signal, 23, 249, 10.1016/j.cellsig.2010.09.009 · DOI · Paper page
- Oda, 2013, Differential requirement for RhoH in development of TCR alpha beta CD8 alpha IELs and other types of T cells, Immunol Lett, 151, 1, 10.1016/j.imlet.2013.02.007 · DOI · Paper page
- Nestle, 2009, Mechanisms of disease: psoriasis, N Engl J Med, 361, 496, 10.1056/NEJMra0804595 · DOI
- Griffiths, 2007, Psoriasis 1—pathogenesis and clinical features of psoriasis, Lancet, 370, 263, 10.1016/S0140-6736(07)61128-3 · DOI
- Lowes, 2014, Immunology of psoriasis, Annu Rev Immunol, 32, 227, 10.1146/annurev-immunol-032713-120225 · DOI
- Ellis, 1986, Cyclosporine improves psoriasis in a double-blind-study, JAMA, 256, 3110, 10.1001/jama.1986.03380220076026 · DOI
- Griffiths, 1987, Topical cyclosporine and psoriasis, Lancet, 1, 806, 10.1016/S0140-6736(87)92829-7 · DOI
- Di Cesare, 2009, The IL-23/Th17 axis in the immunopathogenesis of psoriasis, J Invest Dermatol, 129, 1339, 10.1038/jid.2009.59 · DOI
- Nitta, 2015, The thymic cortical epithelium determines the TCR repertoire of IL-17-producing gammadeltaT cells, EMBO Rep, 16, 638, 10.15252/embr.201540096 · DOI
- Sakaguchi, 2003, Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice, Nature, 426, 454, 10.1038/nature02119 · DOI
- Veldhoen, 2006, Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease, Nat Immunol, 7, 1151, 10.1038/ni1391 · DOI
- Nickoloff, 2007, Cracking the cytokine code in psoriasis, Nat Med, 13, 242, 10.1038/nm0307-242 · DOI
- Dorn, 2007, RhoH is important for positive thymocyte selection and T-cell receptor signaling, Blood, 109, 2346, 10.1182/blood-2006-04-019034 · DOI · Paper page
- Annunziato, 2007, Phenotypic and functional features of human Th17 cells, J Exp Med, 204, 1849, 10.1084/jem.20070663 · DOI · Paper page
- Cai, 2011, Pivotal role of dermal IL-17-producing gamma delta T cells in skin inflammation, Immunity, 35, 596, 10.1016/j.immuni.2011.08.001 · DOI
- Abdallah, 2009, Serum interferon-gamma is a psoriasis severity and prognostic marker, Cutis, 84, 163
- Gunderson, 2013, CD8(+) T cells mediate RAS-induced psoriasis-like skin inflammation through IFN-gamma, J Invest Dermatol, 133, 955, 10.1038/jid.2012.390 · DOI
- Zhu, 2008, Early growth response gene 2 (Egr-2) controls the self-tolerance of T cells and prevents the development of lupuslike autoimmune disease, J Exp Med, 205, 2295, 10.1084/jem.20080187 · DOI
- Kim, 2016, CD1a on Langerhans cells controls inflammatory skin disease, Nat Immunol, 17, 1159, 10.1038/ni.3523 · DOI
- Ma, 2008, IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation, J Clin Invest, 118, 597
- Wagner, 2010, Psoriasis: what we have learned from mouse models, Nat Rev Rheumatol, 6, 704, 10.1038/nrrheum.2010.157 · DOI
- Koga, 2002, In situ localization of IFN-gamma-positive cells in psoriatic lesional epidermis, Eur J Dermatol, 12, 20
- Kryczek, 2008, Induction of IL-17(+) T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis, J Immunol, 181, 4733, 10.4049/jimmunol.181.7.4733 · DOI
- Kleinschek, 2009, Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation, J Exp Med, 206, 525, 10.1084/jem.20081712 · DOI · Paper page
- Cherry, 2004, RhoH is required to maintain the integrin LFA-1 in a nonadhesive state on lymphocytes, Nat Immunol, 5, 961, 10.1038/ni1103 · DOI · Paper page
- Laurence, 2007, Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation, Immunity, 26, 371, 10.1016/j.immuni.2007.02.009 · DOI · Paper page
- Kalia, 2010, Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo, Immunity, 32, 91, 10.1016/j.immuni.2009.11.010 · DOI
- Lin, 2011, Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis, J Immunol, 187, 490, 10.4049/jimmunol.1100123 · DOI · Paper page
- Sutton, 2012, IL-17-producing gamma delta T cells and innate lymphoid cells, Eur J Immunol, 42, 2221, 10.1002/eji.201242569 · DOI
- Wencker, 2014, Innate-like T cells straddle innate and adaptive immunity by altering antigen-receptor responsiveness, Nat Immunol, 15, 80, 10.1038/ni.2773 · DOI
- Muro, 2018, gamma delta TCR recruits the Syk-PI3K axis to drive proinflammatory differentiation program, J Clin Invest, 128, 415, 10.1172/JCI95837 · DOI · Paper page
- Purvis, 2010, Low-strength T-cell activation promotes Th17 responses, Blood, 116, 4829, 10.1182/blood-2010-03-272153 · DOI
- Rutz, 2015, Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells, Nature, 518, 417, 10.1038/nature13979 · DOI
- Hermann-Kleiter, 2015, The nuclear orphan receptor NR2F6 is a central checkpoint for cancer immune surveillance, Cell Rep, 12, 2072, 10.1016/j.celrep.2015.08.035 · DOI
- Favre, 1998, Psoriasis: a possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis, J Invest Dermatol, 110, 311, 10.1046/j.1523-1747.1998.00164.x · DOI
- Ramoz, 1999, A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus, J Invest Dermatol, 112, 259, 10.1046/j.1523-1747.1999.00536.x · DOI
- Tsoi, 2012, Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity, Nat Genet, 44, 1341, 10.1038/ng.2467 · DOI · Paper page
- Tamehiro, 2017, T-cell activation RhoGTPase-activating protein plays an important role in TH17-cell differentiation, Immunol Cell Biol, 95, 729, 10.1038/icb.2017.27 · DOI
- Basu, 2012, Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria, Immunity, 37, 1061, 10.1016/j.immuni.2012.08.024 · DOI
- Nograles, 2008, Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways, Br J Dermatol, 159, 1092
- Moniaga, 2013, Calcipotriol modulates IL-22 receptor expression and keratinocyte proliferation in IL-22-induced epidermal hyperplasia, J Dermatol Sci, 71, 76, 10.1016/j.jdermsci.2013.03.011 · DOI
- Boniface, 2007, A role for T cell-derived interleukin 22 in psoriatic skin inflammation, Clin Exp Immunol, 150, 407, 10.1111/j.1365-2249.2007.03511.x · DOI
- Nikamo, 2014, Genetic variants of the IL22 promoter associate to onset of psoriasis before puberty and increased IL-22 production in T cells, J Invest Dermatol, 134, 1535, 10.1038/jid.2014.5 · DOI
- Saeki, 2013, Genetic polymorphisms in the IL22 gene are associated with psoriasis vulgaris in a Japanese population, J Dermatol Sci, 71, 148, 10.1016/j.jdermsci.2013.04.002 · DOI
- Pan, 2009, Decreased serum IL-22 levels in patients with systemic lupus erythematosus, Clin Chim Acta, 401, 179, 10.1016/j.cca.2008.11.009 · DOI
- da Rocha, 2012, Increased serum interleukin 22 in patients with rheumatoid arthritis and correlation with disease activity, J Rheumatol, 39, 1320, 10.3899/jrheum.111027 · DOI
- Nickoloff, 2007, The cytokine and chemokine network in psoriasis, Clin Dermatol, 25, 568, 10.1016/j.clindermatol.2007.08.011 · DOI
- Martin, 2014, Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid, Mucosal Immunol, 7, 101, 10.1038/mi.2013.28 · DOI
- Hasnain, 2014, Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress, Nat Med, 20, 1417, 10.1038/nm.3705 · DOI
- Wang, 2014, Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes, Nature, 514, 237, 10.1038/nature13564 · DOI
Cited by
The Role of RhoH in TCR Signalling and Its Involvement in Diseases
Ahmad Mokhtar, A. M., Hashim, I. F., Mohd Zaini Makhtar, M., Salikin, N. H., & Amin-Nordin, S. (2021) · Cells · doi:10.3390/cells10040950 · Cited by 25
Peng, S., Stojkov, D., Gao, J., Oberson, K., Latzin, P., Casaulta, C., Yousefi, S., & Simon, H.-U. (2022) · PLOS Biology · doi:10.1371/journal.pbio.3001794 · Cited by 15
Zhou, J., Qian, M., Jiang, N., Wu, J., Feng, X., Yu, M., Min, Q., Xu, H., Yang, Y., Yang, Q., et al. (2024) · Journal of Clinical Immunology · doi:10.1007/s10875-024-01735-4 · Cited by 4
Metadata
- Authors
- Tamehiro, N., Nishida, K., Sugita, Y., Hayakawa, K., Oda, H., Nitta, T., Nakano, M., Nishioka, A., Yanobu-Takanashi, R., Goto, M., Okamura, T., Adachi, R., Kondo, K., Morita, A., & Suzuki, H.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 143
- Issue
- 5
- Pages
- 1878-1891
- ISSN
- 0091-6749
- Cited by
- 25
- References
- 7
- Language
- en
- Funders
- Uehara Memorial Foundation
- Takeda Science Foundation
- Manpei Suzuki Diabetes Foundation
- National Center for Global Health and Medicine (25-103, 26-106)
- Ministry of Education, Culture, Sports, Science and Technology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review